Clinical Trials in Vulnerable Populations

This book Clinical Trials in Vulnerable Populations has 12 chapters divided into 4 sections: Minority Patients, Women, Medically Compromised Patients and Clinical Trials. Contributing authors came from several countries, from Serbia to Turkey. The book was edited by Professor Milica Prostran MD, Ph....

Full description

Bibliographic Details
Main Author: Prostran, Milica
Format: eBook
Language:English
Published: IntechOpen 2018
Subjects:
Online Access:
Collection: Directory of Open Access Books - Collection details see MPG.ReNa
LEADER 01979nma a2200337 u 4500
001 EB002196247
003 EBX01000000000000001333712
005 00000000000000.0
007 cr|||||||||||||||||||||
008 240202 ||| eng
020 |a 9781789232011 
020 |a 66026 
020 |a 9781838812591 
020 |a 9781789232004 
100 1 |a Prostran, Milica 
245 0 0 |a Clinical Trials in Vulnerable Populations  |h Elektronische Ressource 
260 |b IntechOpen  |c 2018 
300 |a 1 electronic resource (224 p.) 
653 |a informed consent, ethics, asthma, imaging, biomedical, probiotic 
653 |a Health psychology / bicssc 
700 1 |a Prostran, Milica 
041 0 7 |a eng  |2 ISO 639-2 
989 |b DOAB  |a Directory of Open Access Books 
500 |a Creative Commons (cc), https://creativecommons.org/licenses/by/3.0/ 
028 5 0 |a 10.5772/66026 
856 4 2 |u https://directory.doabooks.org/handle/20.500.12854/130227  |z DOAB: description of the publication 
856 4 0 |u https://mts.intechopen.com/storage/books/5929/authors_book/authors_book.pdf  |7 0  |x Verlag  |3 Volltext 
082 0 |a 170 
082 0 |a 610 
082 0 |a 100 
520 |a This book Clinical Trials in Vulnerable Populations has 12 chapters divided into 4 sections: Minority Patients, Women, Medically Compromised Patients and Clinical Trials. Contributing authors came from several countries, from Serbia to Turkey. The book was edited by Professor Milica Prostran MD, Ph.D., specialist in Clinical Pharmacology. The potential reader is shown a modern approach to clinical trials in vulnerable populations, from different points of view. The chapters deal at length and clarity with their topics. Finally, I believe, that this book I edited and reviewed with dedication will capture the attention of many readers, from medical students to practicing doctors and pharmacists. All of whom must consider this very important field of medicine: clinical trials in vulnerable patients.